Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.930
+0.270 (7.38%)
Nov 21, 2024, 3:02 PM EST - Market closed
Titan Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 6 | 11 | 10 | 23 | 11 | |
| Market Cap Growth | -47.52% | -45.75% | 13.29% | -56.58% | 109.11% | -35.95% | |
| Enterprise Value | -1 | -1 | 7 | 3 | 25 | 15 | |
| Last Close Price | 3.65 | 8.25 | 15.66 | 20.40 | 65.80 | 116.46 | |
| PS Ratio | 1697.43 | 33.78 | 20.57 | 6.63 | 4.81 | 4.28 | |
| PB Ratio | 0.84 | 0.94 | 8.41 | 1.97 | 6.59 | 7.77 | |
| P/TBV Ratio | 1.28 | 0.94 | 8.41 | 1.97 | 6.59 | 7.77 | |
| EV/Sales Ratio | - | - | 12.97 | 1.98 | 5.08 | 5.59 | |
| Debt / Equity Ratio | - | 0.09 | 0.14 | 0.06 | 0.23 | 3.10 | |
| Asset Turnover | 0.00 | 0.03 | 0.09 | 0.19 | 0.55 | 0.22 | |
| Inventory Turnover | - | - | 23.85 | 18.97 | 14.34 | 5.57 | |
| Quick Ratio | 11.60 | 4.71 | 1.13 | 2.30 | 1.49 | 1.57 | |
| Current Ratio | 12.22 | 5.55 | 1.37 | 2.71 | 1.74 | 2.31 | |
| Return on Equity (ROE) | -368.99% | -139.14% | -313.98% | -202.45% | -298.37% | -181.27% | |
| Return on Assets (ROA) | -172.63% | -74.90% | -106.15% | -72.71% | -52.18% | -41.69% | |
| Return on Capital (ROIC) | -288.58% | -103.87% | -183.11% | -119.58% | -89.95% | -57.85% | |
| Earnings Yield | -163.65% | -89.61% | -89.09% | -86.78% | -78.33% | -147.78% | |
| FCF Yield | -202.70% | -114.15% | -71.43% | -78.34% | -76.19% | -140.98% | |
| Buyback Yield / Dilution | -10.30% | -11.90% | -38.13% | -157.88% | -392.56% | -92.14% | |
| Total Shareholder Return | -10.30% | -11.90% | -38.13% | -157.88% | -392.56% | -92.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.